STEPHANIE TOMICICH: Open Payments
NPI 1316333792 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$824 in 20 payments from 10 companies in 2025. Trend: 2023 $470 · 2024 $913 · 2025 $824
Food & beverage: $824
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $183 |
| Medtronic, Inc. | 1 | $156 |
| Dendreon Pharmaceuticals LLC | 1 | $140 |
| Sumitomo Pharma America, Inc. | 4 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $66 |
| Janssen Scientific Affairs, LLC | 1 | $66 |
| Boston Scientific Corporation | 1 | $39 |
| Myriad Genetic Laboratories, Inc. | 1 | $26 |
| UROGEN PHARMA, INC. | 1 | $22 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
Products named: INTERSTIM, PROVENGE, GEMTESA, BOTOX, Nubeqa, ERLEADA, EPKINLY, LUPRON DEPOT.
Industry payments across CA — which companies pay providers there.
